November 28, 2017 – Dr. Richard Gliklich As artificial intelligence and advanced analytics are increasingly lauded for uses in life sciences and healthcare, it’s becoming difficult to differentiate between the different terms, to understand what is real and what is hype, and to understand how to best leverage these technologies for advancing real-world evidence and[…]
BIG DATA REVEALS 1 OUT OF 6 ER VISITS IN Q2 2017 OPIOID RELATED OM1 launches a prototype for tracking the public health crisis in near real time BOSTON, November 27, 2017 — OM1, a leading AI health outcomes and data company focused on making healthcare more measured, precise and pre-emptive, today announced it has[…]
September 26, 2017 at 2 pm ET – Registries continue to be a critical part of the real-world evidence equation, but over time they have become too trialized, too burdensome, and too separated from real clinical practice. Emerging methodologies, data digitization, and cognitive technologies have set the path for drastic changes needed to address these[…]
September 19, 2017 – 10 am ET Join Kathryn Starzyk, Senior Director of Research and Epidemiology, at OM1, as she discusses the evolving role of big data and cognitive computing in generating real-world evidence for rheumatology and related immunologic disorders. This session will explore how advanced technologies and approaches can be applied to support real-world[…]
Published August 9 – by HealthEconomics.com Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Dr. Rich Gliklich, CEO of OM1, to discuss how big data analytics are changing the face of real world evidence (RWE). HealthEcoOM1logonomics.Com asked Dr. Gliklich to shares his views on major transformational changes in evidence development and how these will[…]
